Moderna co-founder talks COVID-19 vaccines, mRNA growth, agriculture portfolio
Published 2023-02-22Download video
Recommendations
-
06:45 Moderna stock upgraded to outperform by Oppenheimer & Co
-
07:20 Moderna CEO on combo Covid, flu vaccine moving to next trial phase
-
14:16 'I finally got COVID': CBC host | About That
-
1:02:00 Moderna at SXSW 2022 with President Stephen Hoge and FORTUNE Editor-in-Chief Alyson Shontell
-
10:36 Pfizer CEO explains why he hasn't received a vaccine yet
-
05:14 Nvidia still looks relatively inexpensive for its growth trajectory, says Bernstein's Stacy Rasgon
-
07:31 Robinhood CEO’s Plan to Reinvent Investing Again | WSJ
-
04:24 We've only seen the beginning of Moderna's story, says Goldman Sachs' Salveen Richter
-
15:40 CEO Chat with Stéphane Bancel @ Flagship Studio
-
05:49 3 places to invest your money right now: Cashing in on a rally
-
03:19 RNA Vaccines (mRNA Vaccine) - Basis of Pfizer and Moderna COVID-19 vaccines, Animation
-
02:36 Beyond Meat introduces new, healthier burger
-
05:57 Pfizer CEO Albert Bourla on combating vaccine hesitancy and his new book "Moonshot"
-
07:41 Inflation is having a 'creeper effect' on all consumer income levels, analyst says
-
03:20 Jefferies' Michael Yee expects big opportunities for A.I. in the biotech sector
-
02:08 How are the Pfizer and Moderna COVID-19 vaccines different?
-
05:05 FDA advisory panel considers simplifying COVID-19 vaccination schedule
-
05:35 Bernie Sanders calls out Moderna for proposed Covid vaccine price hike
-
02:29 How Americans feel about the economy versus what the data shows
-
24:04 Luminar’s Austin Russell at Alliance for Automotive Innovation’s 2023 #AutoTechShowcase
Similar videos
-
06:46 Moderna CEO discusses earnings and how the company aims to break even by 2026
-
08:44 COVID-19 ‘is not leaving the planet,’ Moderna CEO says
-
09:09 Moderna (MRNA) CFO On Covid Vaccine Demand & Earnings
-
10:06 Moderna will apply ‘same intensity’ for cancer vaccine as it did for COVID, CEO says
-
04:49 Moderna's mRNA RSV vaccine propels stock gains
-
00:31 Our mRNA Plaform
-
03:40 Falling COVID-19 vaccine sales weigh on Moderna’s Q4 earnings results
-
15:12 Moderna CEO Stephane Bancel talks business, vaccine demand, and medical advances
-
01:26 Welcome to the mRNAge
-
03:10 Moderna stock rises on positive results in flu vaccine trial
-
2:41:05 Moderna CEO appears before Senate Hearing on COVID-19 vaccine pricing
-
05:43 The power of mRNA technology and its potential to impact global public health
-
09:22 Moderna CEO Talks New Drugs | Bloomberg Talks
-
04:37 Moderna CEO Stéphane Bancel on promising new data for mRNA cancer vaccine
-
06:12 The science behind Moderna’s vaccine development
-
02:11 Moderna stock declines on mixed flu vaccine trial results
-
05:05 Moderna (MRNA): No Longer A One Hit Wonder?
-
02:18 Moderna stock rises on Q1 earnings, positive vaccine guidance
-
3:08:50 Moderna Annual R&D Day 2022